Dabigatran vs Ipilimumab

## Dabigatran vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Ipilimumab**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Ipilimumab — N/A.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Ipilimumab — N/A.

**Type**: Dabigatran — Small molecule; Ipilimumab — Antibody.